TABLE 2.
Characteristics | Mean ± SD | Range |
---|---|---|
Gender (%) | ||
Female | 68% | |
Male | 32% | |
Age groups, years | ||
1‐18 years | 7.50 ± 8.67 | 0‐30 |
19‐65 years | 75.05 ± 19.74 | 20‐100 |
≥65 years | 17.44 ± 16.55 | 0‐70 |
Lymphedema classification N (%) | ||
Primary | 25.22 ± 20.73 | 0‐90 |
Secondary | 74.78 ± 20.78 | 10‐100 |
Cancer‐related lymphedema | ||
Breast cancer‐related | 47.06 ± 25.96 | 0‐98 |
Other cancer‐related | 6.39 ± 7.64 | 0‐30 |
Non‐cancer‐related lymphedema | ||
Vascular | 10.50 ± 10.17 | 0‐40 |
Trauma/inflammation | 7.61 ± 8.48 | 0‐30 |
Immobility/dependency | 3.33 ± 3.77 | 0‐10 |
Sites of lymphedema | ||
Unilateral upper limb | 50.00 ± 38.35 | 0‐98 |
Bilateral upper limb | 6.22 ± 12.07 | 0‐50 |
Unilateral lower limb | 33.17 ± 31.84 | 0‐90 |
Bilateral lower limb | 36.00 ± 32.53 | 0‐100 |
Head and neck | 1.28 ± 2.71 | 0‐10 |
Trunk/breast | 15.94 ± 23.57 | 0‐80 |
Genitals | 4.27 ± 11.83 | 0‐50 |
Lymphedema Management | ||
Lymphedema management | 82.50 ± 18.60 | 50‐100 |
Wound care+ lymphedema management | 17.50 ± 18.49 | 0‐50 |